Extremity trauma, dressings, and wound infection: Should every acute limb wound have a silver lining?

International Journal of Lower Extremity Wounds

Volumn 11, Issue 3, 2012, Pages 201-212

  Eardley, William G P ^a   Watts, Sarah A ^b   Clasper, Jon C ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

anti infective agents; extremities; local; silver; wounds and injuries

Indexed keywords

CHLORHEXIDINE ACETATE; FUSIDIC ACID; NYSTATIN; PENICILLIN G; SILVER; SILVER NITRATE; SULFADIAZINE; SULFADIAZINE SILVER; SULFONAMIDE;

BANDAGES AND DRESSINGS; BURN; CYTOTOXICITY; DRUG MECHANISM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIMB INJURY; MEDICAL LITERATURE; MEDLINE; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; WOUND CARE; WOUND DRESSING; WOUND HEALING; WOUND INFECTION;

ACUTE DISEASE; ANTI-INFECTIVE AGENTS; BANDAGES; EXTREMITIES; HUMANS; NANOTECHNOLOGY; SILVER COMPOUNDS; WOUND HEALING; WOUND INFECTION; WOUNDS AND INJURIES;

EID: 84866647475     PISSN: 15347346     EISSN: 15526941     Source Type: Journal    
DOI: 10.1177/1534734612457028     Document Type: Review

References (80)

1. Cross JD, Ficke JR, Hsu JR, Masini BD, Wenke JC. Battlefield orthopaedic injuries cause the majority of long-term disabilities. J Am Acad Orthop Surg. 2011 ; 19: S1 - S7
2. Johnson EN, Burns TC, Hayda RA, Hospenthal DR, Murray CK. Infectious complications of open type III tibial fractures among combat casualties. Clin Infect Dis. 2007 ; 45: 409-415
3. Huh J, Stinner DJ, Burns TC, Hsu JR. Late Amputation Study Team. Infectious complications and soft tissue injury contribute to late amputation after severe lower extremity trauma. J Trauma. 2011 ; 71: S47 - S51
4. Nanchahal J, Nayagam S, Khan U, et al Standards for the Management of Open Fractures of the Lower Limb. London, UK: British Association of Plastic, Reconstructive and Aesthetic Surgeons & British Orthopaedic Association ; 2009 :
5. Harris AM, Althausen PL, Kellam J, Bosse MJ, Castillo R. Complications following limb-threatening lower extremity trauma. J Orthop Trauma. 2009 ; 23: 1-6
6. World Health Organization. World Health Day 2011: Combat Antimicrobial Resistance. Geneva, Switzerland: WHO; 2011. http://www.who.int/world-health-day/ 2011/WHD201-FS-EN.pdf. Accessed February 16, 2012.
7. Advanced Trauma Life Support for Doctors. 8 th ed.Chicago, IL: American College of Surgeons; 2008. Chicago, IL: American College of Surgeons ; 2008 :
8. Misra A, Nanchahal J. Use of gauze soaked in povidone iodine for dressing acute open wounds. Plast Reconstr Surg. 2003 ; 111: 2105-2107
9. Bergin SM, Wraight P. Silver based wound dressings and topical agents for treating diabetic foot ulcers. Cochrane Database Syst Rev. 2006 ; ( 1 ):
10. Carter MJ, Tingley-Kelley K, Warriner RA. Silver treatments and silver-impregnated dressings for the healing of leg wounds and ulcers: a systematic review and meta-analysis. J Am Acad Dermatol. 2010 ; 63: 668-679
11. Smith & Nephew. Acticoat™ Antimicrobial barrier dressing. http://global.smith-nephew.com/master/ACTICOAT-27517.htm. Accessed February 28, 2012.
12. British National Formulary. A5.3.3 silver. http://bnf.org/bnf/bnf/ current/202270.htm. Accessed February 28, 2012.
13. Silver dressings: do they work?. Drug Ther Bull. 2010 ; 48: 38-42
14. Lansdown AB. Silver. I: its antibacterial properties and mechanism of action. J Wound Care. 2002 ; 11: 125-130
15. Dunn PM. Dr Carl Credé (1819-1892) and the prevention of ophthalmia neonatorum. Arch Dis Child Fetal Neonatal Ed. 2000 ; 83 (2). F158 - F159
16. Schneider G. Silver nitrate prophylaxis. Can Med Assoc J. 1984 ; 131: 193-196
17. Klasen HJ. Historical review of the use of silver in the treatment of burns: I. Early uses. Burns. 2000 ; 26: 117-130
18. Klasen HJ. A historical review of the use of silver in the treatment of burns: II. Renewed interest for silver. Burns. 2000 ; 26: 131-138
19. Fox CL. Silver sulfadiazine: a new topical therapy for pseudomonas in burns. Therapy of pseudomonas infection in burns. Arch Surg. 1968 ; 96: 184-188
20. Moyer CA. Some effects of 0.5 per cent silver nitrate and high humidity upon the illness associated with large burns. J Natl Med Assoc. 1965 ; 57: 95-100
21. White RJ. An historical overview of the use of silver in wound management. Br J Community Nurs. 2001 ; 6 (8). 3-8
22. Henry G, Garner WL. Inflammatory mediators in wound healing. Surg Clin North Am. 2003 ; 83: 483-507
23. Atiyeh BS, Costagliola M, Hayek SN, Dibo SA. Effect of silver on burn wound infection control and healing: review of the literature. Burns. 2007 ; 33: 139-148
24. Widgerow AD. Chronic wound fluid: thinking outside the box. Wound Repair Regen. 2011 ; 19: 287-291
25. Wright JB, Lam K, Buret AG, Olson ME, Burrell RE. Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing. Wound Repair Regen. 2002 ; 10: 141-151
26. Fong J, Wood F. Nanocrystalline silver dressings in wound management: a review. Int J Nanomedicine. 2006 ; 1: 441-449
27. Identifying criteria for wound infection: position statement. http://ewma.org/fileadmin/user-upload/EWMA/pdf/Position-Documents/ 2005-Wound-Infection-/English-pos-doc-final.pdf. Accessed July 21, 2012.
28. Robson MC. Reconsidering the 10(5) rule. Ostomy Wound Manage. 2003 ; 49: 16
29. Franz MG, Steed DL, Robson MC. Optimizing healing of the acute wound by minimizing complications. Curr Probl Surg. 2007 ; 44: 691-763
30. Lansdown AB. A review of the use of silver in wound care: facts and fallacies. Br J Nurs. 2004 ; 13 (6). S6 - S19
31. Lansdown AB. A pharmacological and toxicological profile of silver as an antimicrobial agent in medical devices. Adv Pharmacol Sci. 2010 ; 2010: 910686
32. Dunn K, Edwards-Jones V. The role of Acticoat™ with nanocrystalline silver in the management of burns. Burns. 2004 ; 30: S1 - S9
33. Ovington LG. The truth about silver. Ostomy Wound Manage. 2004 ; 50: 1S - 10S
34. Stanford W, Rappole BW, Fox CL. Clinical experience with silver sulfadiazine, a new topical agent for control of pseudomonas infections in burns. J Trauma. 1969 ; 9: 377-388
35. Silverlon [product literature]. http://silverlon.com/Clinical-studies
36. 3M™ Tegaderm™ Ag mesh. The power of silver: product monograph. http://multimedia.3m.com/mws/mediawebserver?mwsId=SSSSSu7zK1fslxtUm8- 1o8-xev7qe17zHvTSevTSeSSSSSS - &fn=70-2009-7137-5.pdf. Accessed February 29, 2012.
37. Kumar KS, Van Swygenhoven H, Suresh S. Mechanical behavior of nanocrystalline metals and alloys. Acta Materialia. 2003 ; 51: 5743-5774
38. Wilkinson JM. Micro- and nanotechnology fabrication processes for metals. Med Device Technol. 2004 ; 15: 21-23
39. Gallant-Behm CL, Yin HQ, Liu S, et al. Comparison of in vitro disc diffusion and time kill-kinetic assays for the evaluation of antimicrobial wound dressing efficacy. Wound Repair Regen. 2005 ; 13: 412-421
40. Dowsett C. An overview of Acticoat dressing in wound management. Br J Nurs. 2003 ; 12: S44 - S49
41. Wright JB, Lam K, Burrell RE. Wound management in an era of increasing bacterial antibiotic resistance: a role for topical silver treatment. Am J Infect Control. 1998 ; 26: 572-577
42. Wright JB, Lam K, Hansen D, Burrell RE. Efficacy of topical silver against fungal burn wound pathogens. Am J Infect Control. 1999 ; 27: 344-350
43. Yin HQ, Langford R, Burrell RE. Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Burn Care Rehabil. 1999 ; 20: 195-200
44. Smith & Nephew. ACTICOAT™/ACTICOAT 7 clinical evidence file http://wound.smith-nephew.com/uk/Home.asp. Accessed July 21, 2012.
45. Thomas S, McCubbin P. A comparison of the antimicrobial effects of four silver-containing dressings on three organisms. J Wound Care. 2003 ; 12: 101-107
46. Thomas S, McCubbin P. An in vitro analysis of the antimicrobial properties of 10 silver-containing dressings. J Wound Care. 2003 ; 12: 305-308
47. Holder IA, Durkee P, Supp AP, Boyce ST. Assessment of a silver-coated barrier dressing for potential use with skin grafts on excised burns. Burns. 2003 ; 29: 445-448
48. Fraser JF, Bodman J, Sturgess R, Faoagali J, Kimble RM. An in vitro study of the anti-microbial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream, 1% silver sulphadiazine cream and a silver coated dressing. Burns. 2004 ; 30: 35-41
49. Fraser JF, Cuttle L, Kempf M, Kimble RM. Cytotoxicity of topical antimicrobial agents used in burn wounds in Australasia. ANZ J Surg. 2004 ; 74: 139-142
50. Poon VK, Burd A. In vitro cytotoxicity of silver: implication for clinical wound care. Burns. 2004 ; 30: 140-147
51. Burd A, Kwok CH, Hung SC, et al. A comparative study of the cytotoxicity of silver-based dressings in monolayer cell, tissue explant, and animal models. Wound Repair Regen. 2007 ; 15: 94-104
52. Lam PK, Chan ES, Ho WS, Liew CT. In vitro cytotoxicity testing of a nanocrystalline silver dressing (acticoat) on cultured keratinocytes. Br J Biomed Sci. 2004 ; 61: 125-127
53. Albers CE, Hofstetter W, Siebenrock KA, Landmann R, Klenke FM. In vitro cytotoxicity of silver nanoparticles on osteoblasts and osteoclasts at antibacterial concentrations. Nanotoxicology. :
54. Wasowicz W, Cieslak M, Palus J, et al. Evaluation of biological effects of nanomaterials: part I. Cyto- and genotoxicity of nanosilver composites applied in textile technologies. Int J Occup Med Environ Health. 2011 ; 24: 348-358
55. Martinez-Gutierrez F, Thi EP, Silverman JM, et al. Antibacterial activity, inflammatory response, coagulation and cytotoxicity effects of silver nanoparticles. Nanomedicine. 2012 ; 8: 328-336
56. Li PW, Kuo TH, Chang JH, Yeh JM, Chan WH. Induction of cytotoxicity and apoptosis in mouse blastocysts by silver nanoparticles. Toxicol Lett. 2010 ; 197: 82-87
57. Wei L, Tang J, Zhang Z, Chen Y, Zhou G, Xi T. Investigation of the cytotoxicity mechanism of silver nanoparticles in vitro. Biomed Mater. 2010 ; 5: 044103
58. Wise JPS, Goodale BC, Wise SS, et al. Silver nanospheres are cytotoxic and genotoxic to fish cells. Aquat Toxicol. 2010 ; 97: 34-41
59. Park MV, Neigh AM, Vermeulen JP, et al. The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials. 2011 ; 32: 9810-9817
60. AshaRani PV, Low Kah Mun G, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 2009 ; 3: 279-290
61. Ip M, Lui SL, Poon VKM, Lung I, Burd A. Antimicrobial activities of silver dressings: an in vitro comparison. J Med Microbiol. 2006 ; 55: 59-63
62. Aramwit P, Muangman P, Namviriyachote N, Srichana T. In vitro evaluation of the antimicrobial effectiveness and moisture binding properties of wound dressings. Int J Mol Sci. 2010 ; 11: 2864-2874
63. Castellano JJ, Shafii SM, Ko F, et al. Comparative evaluation of silver-containing antimicrobial dressings and drugs. Int Wound J. 2007 ; 4: 114-122
64. Burrell RE, Heggers JP, Davis GJ, Wright JB. Efficacy of silver-coated dressings as bacterial barriers in a rodent burn sepsis model. Wounds. 1999 ; 11: 64-71
65. Heggers JCWS, Goodheart REMLT, Washington J, et al. Therapeutic efficacy of three silver dressings in an infected animal model. J Burn Care Rehabil. 2005 ; 26: 53-56
66. Ulkur E, Oncul O, Karagoz H, Yeniz E, Celikoz B. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigras), and fusidic acid 2% (Fucidin) for topical antibacterial effect in methicillin-resistant staphylococci-contaminated, full-skin thickness rat burn wounds. Burns. 2005 ; 31: 874-877
67. Ulkur E, Oncul O, Karagoz H, Celikoz B, Cavuslu S. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigras), and silver sulfadiazine 1% (Silverdin) for topical antibacterial effect in pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats. J Burn Care Rehabil. 2005 ; 26: 430-433
68. Acar A, Uygur F, Dikta H, et al. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigras) and nystatin for topical antifungal effect in Candida albicans-contaminated, full-skin-thickness rat burn wounds. Burns. 2011 ; 37: 882-885
69. Uygur F, Oncul O, Evinc R, Diktas H, Acar A, Ulkur E. Effects of three different topical antibacterial dressings on Acinetobacter baumannii- contaminated full-thickness burns in rats. Burns. 2009 ; 35: 270-273
70. Supp AP, Neely AN, Supp DM, Warden GD, Boyce ST. Evaluation of cytotoxicity and antimicrobial activity of acticoat burn dressing for management of microbial contamination in cultured skin substitutes grafted to athymic mice. J Burn Care Rehabil. 2005 ; 26: 238-246
71. Aziz Z, Abu SF, Chong NJ. A systematic review of silver-containing dressings and topical silver agents (used with dressings) for burn wounds. Burns. 2012 ; 38: 307-318
72. Wasiak J, Cleland H, Campbell F. Dressings for superficial and partial thickness burns. Cochrane Database Syst Rev. 2008 ; ( 4 ):
73. Khundkar R, Malic C, Burge T. Use of Acticoat™ dressings in burns: what is the evidence?. Burns. 2010 ; 36: 751-758
74. Huang Y, Li X, Liao Z, et al. A randomized comparative trial between Acticoat and SD-ag in the treatment of residual burn wounds, including safety analysis. Burns. 2007 ; 33: 161-166
75. Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H. Topical silver for preventing wound infection. Cochrane Database Syst Rev. 2010 ; ( 3 ):
76. Lo SF, Chang CJ, Hu WY, Hayter M, Chang YT. The effectiveness of silver-releasing dressings in the management of non-healing chronic wounds: a meta-analysis. J Clin Nurs. 2009 ; 18: 716-728
77. Chaby G, Senet P, Vaneau M, et al. Dressings for acute and chronic wounds: a systematic review. Arch Dermatol. 2007 ; 143: 1297-1304
78. Childress BB, Berceli SA, Nelson PR, Lee WA, Ozaki CK. Impact of an absorbent silver-eluting dressing system on lower extremity revascularization wound complications. Ann Vasc Surg. 2007 ; 21: 598-602
79. Byrnes JM. Necrotizing fasciitis: a common problem in Darwin. Int J Low Extrem Wounds. 2006 ; 5: 271-276
80. Edwards-Jones V. Antimicrobial and barrier effects of silver against methicillin-resistant Staphylococcus aureus. J Wound Care. 2006 ; 15: 285-290